Method to predict or monitor the response of a patient to an ErbB receptor drug

Details for Australian Patent Application No. 2005337051 (hide)

Owner AstraZeneca UK Limited National Cancer Center

Inventors Kasahara, Kazuo; Kimura, Hideharu; Nishio, Kazuto

Agent FB Rice

Pub. Number AU-A-2005337051

PCT Pub. Number WO2007/039705

Priority PCT/ GB2005/03823 05.10.05 GB

Filing date 20 October 2005

Wipo publication date 12 April 2007

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

3 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039705 Priority application(s): WO2007/039705

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005337069-Absorbent article comprising hydrophilic and hydrophobic regions

2005337047-Composition and methods for inhibiting H. pylori adhesion and infection